Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort
Gespeichert in:
Veröffentlicht in: | Journal of the American Academy of Dermatology 2024-07, Vol.91 (1), p.172-175 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 175 |
---|---|
container_issue | 1 |
container_start_page | 172 |
container_title | Journal of the American Academy of Dermatology |
container_volume | 91 |
creator | Peng, Yanmei Kumar, Ashok V. Gu, Zhong Kosuru, Nikhila Wampfler, Jason A. Reck dos Santos, Pedro A. Yu, Nathan Y. D'Cunha, Jonathan Ernani, Vinicius Costello, Collin M. Yang, Ping |
description | |
doi_str_mv | 10.1016/j.jaad.2024.03.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3029812367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962224005401</els_id><sourcerecordid>3029812367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-3f556e090993ceddbd060119d2503c1e6087a8d2534746005b507c12bc626c3e3</originalsourceid><addsrcrecordid>eNp9kEFv1DAQhS0EotvCH-CAfOSSMLYTJ0ZcqkKhUqVeClfL68zuepXYi-0U9s4Px9GWHnuZ0UjvPc37CHnHoGbA5Md9vTdmqDnwpgZRA1cvyIqB6irZ9d1LsgKmoFKS8zNyntIeAFQjutfkTPRtK0HxFfn7BeNkchjD1lmawx9nXT5Sk1KwzmQc6G-XdzSbuMXlMn6gbppmH_IOozk4TNR5mrLZYnXzk_rgqzSZcaQWyxhnv6XWeIuRHkx26HP6RC8pa6ojmkht2IWY35BXGzMmfPu4L8iP66_3V9-r27tvN1eXt5UV0OVKbMrXCAqUEhaHYT2ABMbUwFsQlqGEvjN9uUTTNRKgXbfQWcbXVnJpBYoL8uGUe4jh14wp68ml5U_jMcxJi4KwZ1zIrkj5SWpjSCniRh-im0w8agZ6oa_3eqGvF_oahC7WYnr_mD-vJxyeLP9xF8HnkwBLyweHUSdbmJQyLqLNegjuufx_7ZKWgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3029812367</pqid></control><display><type>article</type><title>Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Peng, Yanmei ; Kumar, Ashok V. ; Gu, Zhong ; Kosuru, Nikhila ; Wampfler, Jason A. ; Reck dos Santos, Pedro A. ; Yu, Nathan Y. ; D'Cunha, Jonathan ; Ernani, Vinicius ; Costello, Collin M. ; Yang, Ping</creator><creatorcontrib>Peng, Yanmei ; Kumar, Ashok V. ; Gu, Zhong ; Kosuru, Nikhila ; Wampfler, Jason A. ; Reck dos Santos, Pedro A. ; Yu, Nathan Y. ; D'Cunha, Jonathan ; Ernani, Vinicius ; Costello, Collin M. ; Yang, Ping</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>ISSN: 1097-6787</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2024.03.029</identifier><identifier>PMID: 38556092</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - therapy ; Cohort Studies ; dermatologic toxicity ; Drug Eruptions - etiology ; Female ; Humans ; Immune Checkpoint Inhibitors - adverse effects ; immunotherapy ; Immunotherapy - adverse effects ; Immunotherapy - methods ; lung cancer ; Lung Neoplasms - drug therapy ; Lung Neoplasms - therapy ; Male ; Middle Aged ; Molecular Targeted Therapy - adverse effects ; Neoplasm Staging ; Retrospective Studies ; survival ; targeted therapy</subject><ispartof>Journal of the American Academy of Dermatology, 2024-07, Vol.91 (1), p.172-175</ispartof><rights>2024 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-3f556e090993ceddbd060119d2503c1e6087a8d2534746005b507c12bc626c3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962224005401$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38556092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peng, Yanmei</creatorcontrib><creatorcontrib>Kumar, Ashok V.</creatorcontrib><creatorcontrib>Gu, Zhong</creatorcontrib><creatorcontrib>Kosuru, Nikhila</creatorcontrib><creatorcontrib>Wampfler, Jason A.</creatorcontrib><creatorcontrib>Reck dos Santos, Pedro A.</creatorcontrib><creatorcontrib>Yu, Nathan Y.</creatorcontrib><creatorcontrib>D'Cunha, Jonathan</creatorcontrib><creatorcontrib>Ernani, Vinicius</creatorcontrib><creatorcontrib>Costello, Collin M.</creatorcontrib><creatorcontrib>Yang, Ping</creatorcontrib><title>Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Aged</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>Cohort Studies</subject><subject>dermatologic toxicity</subject><subject>Drug Eruptions - etiology</subject><subject>Female</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors - adverse effects</subject><subject>immunotherapy</subject><subject>Immunotherapy - adverse effects</subject><subject>Immunotherapy - methods</subject><subject>lung cancer</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Molecular Targeted Therapy - adverse effects</subject><subject>Neoplasm Staging</subject><subject>Retrospective Studies</subject><subject>survival</subject><subject>targeted therapy</subject><issn>0190-9622</issn><issn>1097-6787</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFv1DAQhS0EotvCH-CAfOSSMLYTJ0ZcqkKhUqVeClfL68zuepXYi-0U9s4Px9GWHnuZ0UjvPc37CHnHoGbA5Md9vTdmqDnwpgZRA1cvyIqB6irZ9d1LsgKmoFKS8zNyntIeAFQjutfkTPRtK0HxFfn7BeNkchjD1lmawx9nXT5Sk1KwzmQc6G-XdzSbuMXlMn6gbppmH_IOozk4TNR5mrLZYnXzk_rgqzSZcaQWyxhnv6XWeIuRHkx26HP6RC8pa6ojmkht2IWY35BXGzMmfPu4L8iP66_3V9-r27tvN1eXt5UV0OVKbMrXCAqUEhaHYT2ABMbUwFsQlqGEvjN9uUTTNRKgXbfQWcbXVnJpBYoL8uGUe4jh14wp68ml5U_jMcxJi4KwZ1zIrkj5SWpjSCniRh-im0w8agZ6oa_3eqGvF_oahC7WYnr_mD-vJxyeLP9xF8HnkwBLyweHUSdbmJQyLqLNegjuufx_7ZKWgQ</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Peng, Yanmei</creator><creator>Kumar, Ashok V.</creator><creator>Gu, Zhong</creator><creator>Kosuru, Nikhila</creator><creator>Wampfler, Jason A.</creator><creator>Reck dos Santos, Pedro A.</creator><creator>Yu, Nathan Y.</creator><creator>D'Cunha, Jonathan</creator><creator>Ernani, Vinicius</creator><creator>Costello, Collin M.</creator><creator>Yang, Ping</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202407</creationdate><title>Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort</title><author>Peng, Yanmei ; Kumar, Ashok V. ; Gu, Zhong ; Kosuru, Nikhila ; Wampfler, Jason A. ; Reck dos Santos, Pedro A. ; Yu, Nathan Y. ; D'Cunha, Jonathan ; Ernani, Vinicius ; Costello, Collin M. ; Yang, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-3f556e090993ceddbd060119d2503c1e6087a8d2534746005b507c12bc626c3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>Cohort Studies</topic><topic>dermatologic toxicity</topic><topic>Drug Eruptions - etiology</topic><topic>Female</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors - adverse effects</topic><topic>immunotherapy</topic><topic>Immunotherapy - adverse effects</topic><topic>Immunotherapy - methods</topic><topic>lung cancer</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Molecular Targeted Therapy - adverse effects</topic><topic>Neoplasm Staging</topic><topic>Retrospective Studies</topic><topic>survival</topic><topic>targeted therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peng, Yanmei</creatorcontrib><creatorcontrib>Kumar, Ashok V.</creatorcontrib><creatorcontrib>Gu, Zhong</creatorcontrib><creatorcontrib>Kosuru, Nikhila</creatorcontrib><creatorcontrib>Wampfler, Jason A.</creatorcontrib><creatorcontrib>Reck dos Santos, Pedro A.</creatorcontrib><creatorcontrib>Yu, Nathan Y.</creatorcontrib><creatorcontrib>D'Cunha, Jonathan</creatorcontrib><creatorcontrib>Ernani, Vinicius</creatorcontrib><creatorcontrib>Costello, Collin M.</creatorcontrib><creatorcontrib>Yang, Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peng, Yanmei</au><au>Kumar, Ashok V.</au><au>Gu, Zhong</au><au>Kosuru, Nikhila</au><au>Wampfler, Jason A.</au><au>Reck dos Santos, Pedro A.</au><au>Yu, Nathan Y.</au><au>D'Cunha, Jonathan</au><au>Ernani, Vinicius</au><au>Costello, Collin M.</au><au>Yang, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>91</volume><issue>1</issue><spage>172</spage><epage>175</epage><pages>172-175</pages><issn>0190-9622</issn><issn>1097-6787</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38556092</pmid><doi>10.1016/j.jaad.2024.03.029</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0190-9622 |
ispartof | Journal of the American Academy of Dermatology, 2024-07, Vol.91 (1), p.172-175 |
issn | 0190-9622 1097-6787 1097-6787 |
language | eng |
recordid | cdi_proquest_miscellaneous_3029812367 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aged Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - therapy Cohort Studies dermatologic toxicity Drug Eruptions - etiology Female Humans Immune Checkpoint Inhibitors - adverse effects immunotherapy Immunotherapy - adverse effects Immunotherapy - methods lung cancer Lung Neoplasms - drug therapy Lung Neoplasms - therapy Male Middle Aged Molecular Targeted Therapy - adverse effects Neoplasm Staging Retrospective Studies survival targeted therapy |
title | Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A33%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dermatologic%20toxicity%20associated%20with%20targeted%20and%20immunotherapies%20in%20stage-IV%20non-small%20cell%20lung%20cancer%20patients:%20A%2014-year%20cohort&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Peng,%20Yanmei&rft.date=2024-07&rft.volume=91&rft.issue=1&rft.spage=172&rft.epage=175&rft.pages=172-175&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2024.03.029&rft_dat=%3Cproquest_cross%3E3029812367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3029812367&rft_id=info:pmid/38556092&rft_els_id=S0190962224005401&rfr_iscdi=true |